HER2 testing: The evolving role of immunohistochemistry - best practices and interpretation of results in lung and ovarian cancer  

Tuesday, March 11th 2025
13:30
15:00
EST
17:30
19:00
GMT
18:30
20:00
CET
Login or Create Account to Register for this Meeting
Create Account to Register for this Meeting

Login for this Meeting

About This Meeting

A virtual Experts Knowledge Share on the topic of ‘HER2 testing: The evolving role of immunohistochemistry - best practices and interpretation of results in lung and ovarian cancer’, chaired by Prof. Fernando López-Ríos (Spain) and co-chaired by Prof. Charlie Gourley (UK) and Prof. Christian Rolfo (US).  

Topics of conversation include: 

  1. An overview of challenges related to HER2 immunohistochemistry, practical guidance and interpretation of the results
  2. Targeting HER2 in lung cancer: where does IHC testing fit in?
  3. Ovarian cancer: Challenges and considerations for HER2 IHC testing
  4. A panel discussion amongst speakers and participants engaging in a Q&A to address pressing issues

This event is in collaboration with PRECISION ONCOLOGY CONNECT, a group of international experts in the field of detection and treatment of targetable genetic/genomic alterations in various cancers. 

Don’t miss the opportunity to contribute to the discussion on this important topic.  

Please submit your patient case study/questions for the faculty to selina.gill@cor2ed.com by 28th February 2025 

Meeting Materials

To view meeting materials, you need to be registered for the meeting.

Faculty

Prof. Fernando López-Ríos
Professor of Pathology
12 de Octubre University Hospital, Madrid, Spain
​Prof. Christian Rolfo
Medical Oncologist
The James, The Ohio State University, US
Prof. Charlie Gourley
Medical Oncologist
CRUK Edinburgh Centre, Nicola Murray Centre for Ovarian Cancer Research, UK

Faculty

Prof. Fernando López-Ríos

Professor of Pathology
12 de Octubre University Hospital, Madrid, Spain

​Prof. Christian Rolfo

Medical Oncologist
The James, The Ohio State University, US

Prof. Charlie Gourley

Medical Oncologist
CRUK Edinburgh Centre, Nicola Murray Centre for Ovarian Cancer Research, UK
PRECISION ONCOLOGY CONNECT is an initiative of COR2ED. This programme is supported by an Independent Medical Education Grant from AstraZeneca.

COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Switzerland
Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved 
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept